Feedback / Questions
CLSP-1025 - Clasp Therapeutics
https://www.businesswire.com/news/home/20250428515244/en/Clasp-Therapeutics-Doses-First-Patient-in-Phase-1-Clinical-Trial-With-a-First-in-Class-T-Cell-Engager-Designed-to-Target-Cancer-Cells-With-Absolute-Specificity
Apr 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next